Udo Schneider
Impact in
- Pharmacology top 0.5%
- Cannabis and Cannabinoid Research
- Rheumatology top 0.5%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
Papers in
- Epidemiology 56
- Inflammatory Myopathies and Dermatomyositis 31
- Substance Abuse Treatment and Outcomes 8
- Pharmacology 34
- Cannabis and Cannabinoid Research 25
- Co-authors
- H. M. Emrich (31 shared papers)F. Markus Leweke (10 shared papers)HANS KOLBE (7 shared papers)Kirsten Müller‐Vahl (13 shared papers)Hinderk Meiners Emrich (16 shared papers)Jens Dieter Rollnik (12 shared papers)Matthias Karst (12 shared papers)Thomas J. Huber (9 shared papers)
- Journals
- Annals of the Rheumatic Diseases (14 papers)Lara D. Veeken (8 papers)Addiction Biology (8 papers)Pharmacopsychiatry (7 papers)Alcohol and Alcoholism (6 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Udo Schneider
279 papers receiving 8.4k citations
Udo Schneider's Hit Papers
Peers
Comparison fields: 5 of 172
- Pharmacology 1.7k
- Rheumatology 1.2k
- Biological Psychiatry 187
- Cellular and Molecular Neuroscience 1.1k
- Toxicology 199
Countries citing papers authored by Udo Schneider
This map shows the geographic impact of Udo Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Udo Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Udo Schneider more than expected).
Fields of papers citing papers by Udo Schneider
This network shows the impact of papers produced by Udo Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Udo Schneider. The network helps show where Udo Schneider may publish in the future.
Co-authors
The 25 scholars most cited alongside Udo Schneider, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 308 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Plasmablastic Lymphomas of the Oral Cavity: A New Entity Associated With the Human Immunodeficiency Virus Infection Hit paper breakdown → | 1997 | 687 |
| 2 | Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT) Hit paper breakdown → | 2005 | 545 |
| 3 | 2002 | 284 | |
| 4 | 2003 | 266 | |
| 5 | 2020 | 253 | |
| 6 | 2003 | 218 | |
| 7 | 2006 | 218 | |
| 8 | 2008 | 202 | |
| 9 | 1997 | 196 | |
| 10 | 2002 | 196 | |
| 11 | 2019 | 159 | |
| 12 | 2000 | 146 | |
| 13 | Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT). | 2008 | 140 |
| 14 | 2000 | 127 | |
| 15 | 2008 | 124 | |
| 16 | 2005 | 107 | |
| 17 | 2018 | 102 | |
| 18 | 2001 | 100 | |
| 19 | 2005 | 100 | |
| 20 | 2001 | 94 |
About Udo Schneider
Udo Schneider is a scholar working on Epidemiology, Pharmacology, Rheumatology, Psychiatry and Mental health and Cellular and Molecular Neuroscience, having authored 308 papers that have together received 9.0k indexed citations. Recurring topics across this work include Inflammatory Myopathies and Dermatomyositis (31 papers), Cannabis and Cannabinoid Research (25 papers), Neurotransmitter Receptor Influence on Behavior (14 papers), Vasculitis and related conditions (12 papers), Neuroscience and Neuropharmacology Research (11 papers), Systemic Sclerosis and Related Diseases (9 papers), Eosinophilic Disorders and Syndromes (9 papers) and Substance Abuse Treatment and Outcomes (8 papers). The work is most often cited by research in Pharmacology (1.7k citations), Rheumatology (1.2k citations), Biological Psychiatry (187 citations), Cellular and Molecular Neuroscience (1.1k citations) and Toxicology (199 citations). Udo Schneider has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include H. M. Emrich, F. Markus Leweke, HANS KOLBE, Kirsten Müller‐Vahl, Hinderk Meiners Emrich, Jens Dieter Rollnik, Matthias Karst, Thomas J. Huber, Gerd Rüdiger Burmester and SUMNER H. BURSTEIN. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Addiction Biology, Pharmacopsychiatry and Alcohol and Alcoholism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.